Plain-English translation of NCT07116174 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing (XAM), a treatment made from amniotic membrane that is applied directly to diabetic foot ulcers. Researchers want to see if adding this treatment to your regular wound care helps ulcers heal completely within 12 weeks, compared to standard care alone. The study will enroll about 135 people with diabetic foot ulcers that haven't healed with typical treatment.
Diabetic foot ulcers are difficult to heal and can lead to serious complications, including infection or amputation. Doctors are looking for new treatments that, when combined with standard wound care, might help these stubborn ulcers close faster and more reliably.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will visit the clinic once a week for 12 weeks to receive the treatment applied to your ulcer. You'll continue your regular wound care (dressing changes, off-loading your foot if needed) during this time. After the 12-week treatment period ends, you'll return for one follow-up visit two weeks later so the researchers can see how well your ulcer has healed.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States